← Eichor
Condition: Stage Ii Prostate Cancer Ajcc V8 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Stage Ii Prostate Cancer Ajcc V8

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06995053Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
Phase 2 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06330805FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer,
Phase 2 · 6 location(s) · Northwestern University · NCT06244004Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT04734730SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
Phase 3 · 6 location(s) · Mayo Clinic · NCT06205316Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Can
Phase 2 · 13 location(s) · National Cancer Institute (NCI) · NCT05691465Vitamin D for Prostate Endocrine Therapy
Phase 3 · 51 location(s) · University of Rochester · NCT05838716Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly S
NA · 1 location(s) · Roswell Park Cancer Institute · NCT03880422Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
NA · 5 location(s) · Mayo Clinic · NCT06325046High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT04945642Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer
Phase 4 · 1 location(s) · Roswell Park Cancer Institute · NCT06733350rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveil
EARLY_Phase 1 · 1 location(s) · Northwestern University · NCT05852041MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
NA · 1 location(s) · Mayo Clinic · NCT05438563Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer
NA · 1 location(s) · University of California, Davis · NCT06178354Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07468903Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Pr
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06067269Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Ca
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07276438Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy
NA · 1 location(s) · Mayo Clinic · NCT06940271Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT04947254Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
NA · 2 location(s) · University of Southern California · NCT06500169Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patie
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT04775355Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
NA · 1 location(s) · Mayo Clinic · NCT06389786Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer
Phase 2 · 1 location(s) · University of California, Davis · NCT06173362Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · 582 location(s) · National Cancer Institute (NCI) · NCT03866382Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Phase N/A · 745 location(s) · Alliance for Clinical Trials in Oncology · NCT05334069Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Phase 2 · 1 location(s) · University of Utah · NCT05168618Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Phase 1/Phase 2 · 1 location(s) · Vadim S Koshkin · NCT05113537Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · 133 location(s) · SWOG Cancer Research Network · NCT05806515
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.